Showing 1671-1680 of 4065 results for "".
CDC - TB & HIV: A Deadly Duo, Part 2
https://reachmd.com/programs/grand-rounds-nation/cdc-tb-hiv-a-deadly-duo-part-2/6391/The CDC commemorates Dr. Robert Koch's 1882 discovery of Mycobacterium tuberculosis, the bacteria that causes TB. Over the past 129 years, history has witnessed many advances over in TB control. Through the intervention efforts of CDC, USAID, WHO's Stop TB Partnership, and many others, TB deathGuideline Recommendations in First-Line Treatment of HER2-Negative Upper GI Cancers
https://reachmd.com/programs/cme/guideline-recommendations-in-first-line-treatment-of-her2-negative-upper-gi-cancers/37689/Partnering with Patients: Improving First-Line Treatment Selection in Upper GI Cancers Through Shared Decision-MakingPivotal Data in Anti-PD-1 Strategies for HER2-Negative Upper GI Cancers
https://reachmd.com/programs/cme/pivotal-data-in-anti-pd-1-strategies-for-her2-negative-upper-gi-cancers/37690/Partnering with Patients: Improving First-Line Treatment Selection in Upper GI Cancers Through Shared Decision-MakingQuick Case: Strategizing Treatment Selection in HER2-/PD-L1+ Gastric Cancer
https://reachmd.com/programs/cme/quick-case-strategizing-treatment-selection-in-her2-pd-l1-gastric-cancer/37692/Partnering with Patients: Improving First-Line Treatment Selection in Upper GI Cancers Through Shared Decision-MakingDistinguishing First-Line Treatment Adverse Event Profiles in HER2-Negative Upper GI Cancers
https://reachmd.com/programs/cme/distinguishing-first-line-treatment-adverse-event-profiles-in-her2-negative-upper-gi-cancers/37691/Partnering with Patients: Improving First-Line Treatment Selection in Upper GI Cancers Through Shared Decision-MakingAchieving Success in IgAN & FSGS
https://reachmd.com/programs/cme/achieving-success-in-igan-fsgs/14677/Review underlying mechanisms of glomerulonephritis and sclerosis in patients with IgAN and FSGS and find out how emerging data may improve outcomes.Partnering with Patients: Improving First-Line Treatment Selection in Upper GI Cancers Through Shared Decision-Making
https://reachmd.com/programs/cme/partnering-with-patients-improving-first-line-treatment-selection-in-upper-gi-cancers-through-shared-decision-making/36579/Partnering with Patients: Improving First-Line Treatment Selection in Upper GI Cancers Through Shared Decision-MakingGenerating More Than Buzz
https://reachmd.com/topics/practice-development/generating-more-than-buzz/35419/Pioneers in the field share key information at Genesis: Innovations in Aesthetic Regenerative MedicineUnderstanding the Skin–Mind Connection in Neurocosmetics
https://reachmd.com/ma-issues-index/march-april-2026-issue/understanding-the-skinmind-connection-in-neurocosmetics/56636/Neurocosmetics tap the skin–brain axis to influence both cutaneous function and emotional well-beingCADASIL Misdiagnosed as Multiple Sclerosis
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/cadasil-misdiagnosed-as-multiple-sclerosis/36652/The authors present a case of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy misdiagnosed as multiple sclerosis.